Related references
Note: Only part of the references are listed.Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog et al.
NATURE REVIEWS CARDIOLOGY (2022)
The Non-Activated Thromboelastometry (NATEM) Assay's Application among Adults and Neonatal/Pediatric Population: A Systematic Review
Petroula Georgiadou et al.
DIAGNOSTICS (2022)
Inflammatory and thrombotic parameters associated with the COVID-19 course in Poland (SARSTer study)
Piotr Czupryna et al.
ADVANCES IN MEDICAL SCIENCES (2022)
C-reactive protein and clinical outcomes in patients with COVID-19
Nathaniel R. Smilowitz et al.
EUROPEAN HEART JOURNAL (2021)
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Sean X. Gu et al.
NATURE REVIEWS CARDIOLOGY (2021)
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Yu Zuo et al.
SCIENTIFIC REPORTS (2021)
The Role of TEG Analysis in Patients with COVID-19-Associated Coagulopathy: A Systematic Review
Jan Hartmann et al.
DIAGNOSTICS (2021)
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 A Systematic Review and Meta-analysis
David Jimenez et al.
CHEST (2021)
The Central Role of Fibrinolytic Response in COVID-19-A Hematologist's Perspective
Hau C. Kwaan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Viscoelastometric Testing to Assess Hemostasis of COVID-19: A Systematic Review
Marion Bareille et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Serial EXTEM, FIBTEM, and tPA Rotational Thromboelastometry Observations in the Maastricht Intensive Care COVID Cohort-Persistence of Hypercoagulability and Hypofibrinolysis Despite Anticoagulation
Anne-Marije Hulshof et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?
Paul A. Gurbel et al.
BLOOD COAGULATION & FIBRINOLYSIS (2021)
International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests
Paul A. Gurbel et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2021)
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Ewan C. Goligher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19
Abakar Magomedov et al.
SCIENTIFIC REPORTS (2021)
Platelet activation in critically ill COVID-19 patients
Nader Yatim et al.
ANNALS OF INTENSIVE CARE (2021)
Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge
Anne-Marije Hulshof et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2021)
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis
Preeti Malik et al.
BMJ EVIDENCE-BASED MEDICINE (2021)
C-reactive protein and clinical outcomes in patients with COVID-19
Nathaniel R. Smilowitz et al.
EUROPEAN HEART JOURNAL (2021)
Thromboinflammation and the hypercoagulability of COVID-19
Jean M. Connors et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia
Vittorio Pavoni et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2020)
COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness
Argirios E. Tsantes et al.
DIAGNOSTICS (2020)
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis
Stephan Nopp et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding
Pawel Rogalski et al.
THROMBOSIS RESEARCH (2019)
TEG and ROTEM: Technology and clinical applications
David Whiting et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Potentiation of platelet aggregation by heparin in human whole blood is attenuated by P2Y(12) and P2Y(1) antagonists but not aspirin
RF Storey et al.
THROMBOSIS RESEARCH (2005)